How should a patient with urinary incontinence and hand pain be evaluated and managed for possible cervical myelopathy?

Evaluation and Management of Suspected Cervical Myelopathy with Urinary Incontinence and Hand Pain

MRI of the cervical spine without contrast is the initial imaging study of choice for evaluating suspected cervical myelopathy in a patient presenting with urinary incontinence and hand pain. 1

Clinical Recognition

The combination of urinary incontinence and hand pain strongly suggests cervical myelopathy and warrants urgent evaluation. Key clinical features to assess include:

• Upper extremity dysfunction: Loss of manual dexterity, hand clumsiness, difficulty with fine motor tasks (buttoning, writing), and hand weakness 2, 3, 4
• Gait disturbance: Unsteady walking, broad-based gait, difficulty with balance 2, 3
• Bladder dysfunction: Urinary urgency, frequency, hesitancy, or incontinence occurs in 20-53% of patients with pure cervical spondylotic myelopathy 5, 6
• Upper motor neuron signs: Hyperreflexia, positive Hoffman sign, sustained clonus, positive Babinski sign 2, 3
• Lhermitte sign: Electric shock sensation down the spine with neck flexion 2
• Sensory changes: Paresthesias, decreased proprioception, impaired pain sensation 2, 3

Diagnostic Imaging Approach

MRI is the mainstay for evaluating myelopathy due to its superior contrast resolution of the spinal cord. 1 The 2021 ACR Appropriateness Criteria designate MRI cervical spine without contrast as "usually appropriate" (rating 7-9) for initial imaging. 1

Imaging Considerations:

• Entire spine imaging may be beneficial even when clinical findings suggest a specific level, as multilevel pathology is common 1
• Brain MRI may be useful as an adjunct to exclude alternative diagnoses such as multiple sclerosis 1
• CT myelography is reserved for patients with MRI contraindications (pacemakers, severe claustrophobia) or when additional osseous detail is needed 1, 7

Prognostic MRI Findings:

• Spinal cord transverse area <30 mm² predicts worse surgical outcomes 8
• T2 hyperintensity with T1 hypointensity indicates more severe cord injury and poorer prognosis 8
• Multisegmental T2 hyperintensity correlates with worse outcomes compared to focal changes 8

Functional Assessment

Use disease-specific scales to quantify severity:

• Modified Japanese Orthopaedic Association (mJOA) scale: Scores ≤12 indicate moderate-to-severe myelopathy requiring surgical consideration 9, 10, 11
• Nurick Classification: Grades functional impairment from 0 (signs only) to 5 (wheelchair-bound) 2, 11

The mJOA includes a specific urinary function subscore that tracks bladder control 10, 5

Urological Evaluation

Not all urinary symptoms in cervical myelopathy patients represent neurogenic bladder. 5, 6

• 28% of patients with urinary complaints have non-neurogenic urologic disorders requiring separate evaluation 6
• Urodynamic studies have limited diagnostic value in cervical myelopathy, as only 25% of patients with urinary complaints show neurogenic bladder on formal testing 5, 6
• Urinary complaints correlate with longer disease duration and delayed motor evoked potentials rather than myelopathy severity scores 6
• Cystoscopy is indicated for patients with hematuria, recurrent UTIs, or suspected anatomic abnormalities 12

Management Decision Algorithm

Mild Myelopathy (mJOA >12):

• Either surgical decompression or conservative management (cervical collar immobilization, activity modification, anti-inflammatory medications) is acceptable for the first 3 years 9
• Close monitoring for progression is essential 9

Moderate-to-Severe Myelopathy (mJOA ≤12):

Surgical decompression is recommended with benefits maintained for 5-15 years postoperatively. 9

Surgical Approach Selection:

• Anterior cervical discectomy and fusion (ACDF) or anterior cervical corpectomy and fusion (ACCF) for anterior compression at disc levels, with equivalent outcomes when anterior plating is used 13
• Laminoplasty or laminectomy with fusion for multilevel posterior compression 14, 13
• Laminectomy alone has higher rates of late deterioration and postoperative kyphosis compared to other techniques, though kyphosis development may not diminish clinical outcomes 14, 13

Urinary Function Prognosis

77.5% of patients with baseline urinary dysfunction experience improvement at 2 years post-surgery, though recovery rates are lower than for other myelopathy symptoms. 10

• Women are more likely to improve urinary function after surgery than men (54.9% vs 45.1%) 10
• 90% of patients with urinary complaints show recovery after surgical decompression 6
• Urinary complaints alone may justify surgical intervention even without definitive urodynamic confirmation of neurogenic bladder 6

Critical Pitfalls to Avoid

• Do not delay imaging when myelopathy is suspected—early diagnosis prevents irreversible neurological decline 2, 4
• Do not rely solely on MRI findings without clinical correlation, as asymptomatic cord compression is common and MRI has both false-positive and false-negative findings 7, 2
• Do not assume all urinary symptoms are neurogenic—refer to urology for evaluation of alternative causes 5, 6
• Do not perform surveillance urine cultures in asymptomatic patients, as this promotes antibiotic resistance without clinical benefit 12
• Do not treat asymptomatic bacteriuria except in pregnant patients or before urologic procedures 12